Better diagnosis methods can reduce the risk of complications, at the same time as it cuts costs and reduces human suffering. Vinnova, Sweden's governmental innovation agency, acknowledges the potential in Pernilla Abrahamsson's unique microdialysis technique, which opens the door to faster, easier, and more accurate diagnostics of severely ill patients. This is why Vinnova has selected Pernilla's project, as one of 10 among a total of 48 applications, to gain VINN-verifiering financing. This means that the microdialysis project is granted financing for the first in a series of milestones. If the project reaches all future milestones, the project will be able to receive a total of 2 million SEK from Vinnova.
The 30 participants to Biotech Umeå's and Umeå Biotech Incubator's network event had to defy a biting April rain in order to take part at the meeting. The meeting itself, which took place at Umeå Arts Campus by a still frozen Umeälven, offered an afternoon full with food for both thought and stomach.The topics of the event was how you can facilitate the progress of product development by cooperating with the Innovation office at the Medical Products Agency, MPA, and information about the financial and advisory support the SME companies can get from ALMI and other organizations. The evening ended with an opportunity to mingle and interact over a buffet dinner.
Tillväxtverket har tillsammans med regionala partnerskap en extra satsning för tillväxt i små och medelstora företag genom programmet Affärsutvecklingscheckar.
Västerbottens läns landsting och Innovationssluss Västerbotten har tillsammans med Uminova Innovation utarbetat ett unikt fribrev som ger landstingsanställda rätten att äga sin egen idé. Det är det första avtalet i norra Sverige och det andra i Sverige.
On January 31, Biotech Umeå Investment Day took place at Grand Hôtel Stockholm. The day started with partnering sessions between companies from the Umeå region and 15 investors from Scandinavia and abroad – in total, over 50 partnering meetings took place during three hours. In the afternoon, more investors and other guests arrived to participate in the afternoon program, which attracted a total of 65 people.
The natural compound INP-11252 has been shown to have an effect on progression in a Pseudomonas aeruginosa pulmonary infection model.
Are you a researcher with a potential business idea? ... but have no time to work on it – here’s your chance. In the Academic Business Challenge a team of students evaluate the business potential of a researcher’s idea. Researchers from all faculties are welcome to apply. 6-9 ideas will be chosen for participation.
Stefan Nilsson, Gunilla Olivecrona and Mikael Elofsson's UBI project to develop drugs against cardiovascular problems, is supported by Vinnova with 2 million SEK.
Despite vast improvements in available treatments over the decades, only one in four heart attacks can be prevented, making cardiovascular disease the most common cause of death in Sweden and in the world. The project's research trio aim at reducing the risk for cardiovascular disease, thus hopefully improving the quality of life for millions of people.
Umeå-based medical technology company Likvor is working intensively with its international launch of the patented Likvor CELDA® System, and recently received a prestigious order from the Netherlands. The system can provide millions of dementia patients a way back to life, and has attracted much attention.
At the end of November, Uminova Innovation, InfoTech Umeå and Biotech Umeå organized a course for CEOs.
Since several years there is an academic collaboration between Umeå University and Tromsö University (Molecules for the future) in Norway. Biotech Umeå would like to expand the collaboration with contacts to the Tromsö biotech cluster, Biotech North
What have I learned? Patrik Appelblad
What have I learned? Mats Strömqvist
Swedish national meeting for companies in the field of infection
Biotech Umeå, Uminova Innovation AB,
Box 7978, 907 19 Umeå, Tel: 090 15 48 40